Navigation Links
Non-Profit Breastcancer.org Shares Concerns with FDA on Avastin Breast Cancer Recommendation
Date:12/16/2010

ARDMORE, Pa., Dec. 16, 2010 /PRNewswire-USNewswire/ -- Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer.  In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.

Breastcancer.org's position remains unchanged by today's ruling.  

Dear ODAC Committee Members:

As you consider label changes for Avastin, Breastcancer.org asks you to consider the treatment needs, expectations, and preferences of women diagnosed with metastatic breast cancer. In contrast to most women with early-stage breast cancer, most women with metastatic disease need continuous treatment in order to live. Despite the desperation many people with metastatic disease experience, they often have a remarkable ability to measure the pros and cons of each treatment decision with purpose, clarity, and precision. No two women or their cancers nor their treatment histories are the same. Aggregate clinical trial results include individuals with greater than expected benefit as well as those with a disappointing response. We doctors are limited in our ability to figure out who will and who won't get the important benefit of any particular treatment whether in the first-line setting or beyond. But we must have treatment options to turn to for our patients who need and desire them. Women with metastatic disease are prepared to make treatment decisions with greater risk since prior forms of treatments have already failed them. They deserve that choice.

As a non-profit organization dedicated to providing the most reliable, complete, and up-to-date information about breast health and br
'/>"/>

SOURCE Breastcancer.org
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Independent Committee of Caraco Board to Consider Sun Pharma Proposal to Purchase Outstanding Shares
2. Caraco Receives Sun Pharma Proposal to Purchase All Outstanding Shares
3. Cannabis Science Announces a Proposed 10:1 Ratio Structured Dividend Payout for a New Class of Common Shares to Shareholders of Record as of November 30, 2010
4. Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.
5. Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
6. Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash
7. Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Penwest Pharmaceuticals
8. Reportlinker Adds Portable and Transport Ventilator Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016
9. Essilor Cancels Four Million Shares
10. Watson Completes Acquisition of CRINONE® and PROCHIEVE® Product Line and Shares of Columbia Laboratories
11. Hospira Announces Intention to Complete Tender Offer for Shares of Javelin Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ...
(Date:1/15/2014)... wearable injector slightly larger than an Oreo cookie may soon ... drugs in the large doses required to treat a wide ... genetic disorders.  An emerging biologic drugs market ... analysts.   Many of these drugs will require a new type ...
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of ... Home Medical Equipment, Inc. ("Progressive") of Clarion, PA ... acquisition were not disclosed. Progressive is a ... range of sleep, mobility, and respiratory products to customers in ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
(Date:4/17/2014)... new pain relief targets that could be used ... at King,s College London made the discovery when ... periphery of the body. , Dr Marzia Malcangio ... underlying pain generation and our findings could help ... , One potential side effect of some chemotherapy ...
(Date:4/17/2014)... April issue of Experimental Biology and Medicine ... Rex Gaskins and Paul Kenis in the Institute ... the University of Illinois Urbana-Champaign describe their recent ... underlie a variety of cell functions including energy ... crucial roles in regulating normal cellular behavior, redox ...
(Date:4/17/2014)... MANHASSET, NY In a review published in the ... MD, president of The Feinstein Institute for Medical Research, ... the medical community,s approach to treating sepsis, ... 200,000 Americans. , Sepsis occurs when molecules released into ... inflammation throughout the body. Inflammation is necessary for maintaining ...
(Date:4/17/2014)... personnel who served in Iraq and Afghanistan and ... (TBI) were compared to military personnel without TBI ... in measures of overall disability, cognitive function, post-traumatic ... reported in an article in Journal of ... Liebert, Inc., publishers. The article is available free ...
(Date:4/17/2014)... The cause of neuronal death in Parkinson,s disease ... neurons may be mistaken for foreign invaders and killed ... way autoimmune diseases like type I diabetes, celiac disease, ... was published April 16, 2014, in Nature Communications ... idea in Parkinson,s disease; but if true, it could ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Is Parkinson's an autoimmune disease? 2
... study published in the Lancet has revealed how British American ... strategy to mask the toxicity of the manufactured cigarettes. // ... of the company by Canadian researchers, it has been found ... nicotine under real life situations, while in documentation, it was ...
... at the University of Iowa Roy J. and Lucille A. ... (PET) technology can help // doctors gauge the response of ... and co-author Bruce Cheson, M.D., of the Lombardi Comprehensive Cancer ... usage of PET n gauging the response of the tumor ...
... service policy acceptance in schools it has been found ... directors' perceptions. // ,They have different ideas ... among key stakeholders addressing new wellness policy development mandated ... 2004. ,'Competitive foods are those sold ...
... respiratory illness as a result of breast-feeding, according to a ... belonging to the age group of 6 years to 24 ... They identified five groups, formula-fed only, full breastfeeding for ... months, full breastfeeding from four to less than six months, ...
... the wrong reasons. Blaming the government of apathy over the ... post of Chief Scientific Officer at the Department of Health, has ... vaccine adequately, despite a lurking fear of autism, as a probable ... it could turn out to be the worst disgrace in medical ...
... Health Grade, a health ratings company, the top 5 % ... to lower the risk of death to patients by ... risk of complications. //,Health Grades, as part of their ... in the United States. ,Death and complication rates for ...
Cached Medicine News:Health News:Clash of Difference of perceptions in food policy among Principals’ and Director 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: